Spontaneous regression of lung metastasis in the absence of tumor necrosis factor receptor p55

被引:30
作者
Tomita, Y
Yang, XQ
Ishida, Y
Nemoto-Sasaki, Y
Kondo, T
Oda, M
Watanabe, G
Chaldakov, GN
Fujii, C
Mukaida, N
机构
[1] Kanazawa Univ, Canc Res Inst, Div Mol Bioregulat, Kanazawa, Ishikawa 9200934, Japan
[2] Kanazawa Univ, Dept Thorac Cardiovasc & Gen Surg, Grad Sch Med, Kanazawa, Ishikawa 9200934, Japan
[3] Kanazawa Univ, Canc Res Inst, Ctr Dev Mol Target Drugs, Kanazawa, Ishikawa 9200934, Japan
[4] Wakayama Med Univ, Dept Legal Med, Wakayama, Japan
关键词
neovascularization; tumor necrosis factor; hepatocyte growth factor;
D O I
10.1002/ijc.20493
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In order to clarify the roles of tumor necrosis factor (TNF)-alpha in lung metastasis, we injected Renca cells intravenously into TNF receptor p55-deficient (TNF-Rp55 KO) and wild-type (WT) mice. Microscopic and macroscopic metastasis foci appeared in lungs at 7 and 14 days after the tumor injection, respectively. Moreover, metastasis foci expanded at similar rates in both WT and TNF-Rp55 KO mice until 21 days, and lungs were occupied with metastasis foci. However, later than 21 days after the injection, metastasis foci spontaneously regressed in TNF-Rp55 KO mice, whereas WT mice exhibited a progressive growth of metastasis foci. Moreover, metastasis foci remained reduced sizes in TNF-Rp55 KO mice even at 26 days, when all WT mice died with lungs filled with metastasis foci. Later than 21 days after the tumor injection, the number of apoptotic tumor cells was increased in TNF-Rp55 KO mice. In contrast, neovascularization was less evident in TNF-Rp55 KO than WT mice, with depressed hepatocyte growth factor (HGF) gene in TNF-Rp55 KO mice at 21 days after the tumor injection. Thus, TNF-Rp55-mediated signals can maintain tumor neovascularization at least partly by inducing HGF expression, and eventually support lung metastasis process. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:927 / 933
页数:7
相关论文
共 40 条
[31]   ANTIMETASTATIC EFFECT OF ENDOGENOUS TUMOR NECROSIS FACTOR INDUCED BY THE TREATMENT OF RECOMBINANT INTERFERON-GAMMA FOLLOWED BY AN ANALOG (GLA-60) TO SYNTHETIC LIPID-A SUBUNIT [J].
SAIKI, I ;
MAEDA, H ;
MURATA, J ;
YAMAMOTO, N ;
KISO, M ;
HASEGAWA, A ;
AZUMA, I .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1989, 30 (03) :151-157
[32]   Infliximab maintenance therapy for fistulizing Crohn's disease [J].
Sands, BE ;
Anderson, FH ;
Bernstein, CN ;
Chey, WY ;
Feagan, BG ;
Fedorak, RN ;
Kamm, MA ;
Korzenik, JR ;
Lashner, BA ;
Onken, JE ;
Rachmilewitz, D ;
Rutgeerts, P ;
Wild, G ;
Wolf, DC ;
Marsters, PA ;
Travers, SB ;
Blank, MA ;
van Deventer, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (09) :876-885
[33]   ANTI-TUMOR EFFECT OF RECOMBINANT MURINE TNF-ALPHA (RMUTNFA) GIVEN BY CONTINUOUS IV INFUSION AS COMPARED TO REPEATED IV INJECTIONS IN A RAT-LIVER METASTASIS MODEL [J].
SCHERINGA, M ;
KEIZER, A ;
JEEKEL, J ;
MARQUET, RL .
INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (05) :905-909
[34]   PROTECTIVE ACTIVITY OF RECOMBINANT MURINE TUMOR NECROSIS FACTOR-ALPHA AND INTERFERON-GAMMA AGAINST EXPERIMENTAL MURINE LUNG-CARCINOMA METASTASES [J].
SCHULTZ, RM ;
ALTOM, MG .
JOURNAL OF INTERFERON RESEARCH, 1990, 10 (02) :229-236
[35]   TNFerade biologic, an adenovector with a radiation-inducible, promoter, carrying the human tumor necrosis factor alpha gene: A phase I study in patients with solid tumors [J].
Senzer, N ;
Mani, S ;
Rosemurgy, A ;
Nemunaitis, J ;
Cunningham, C ;
Guha, C ;
Bayol, N ;
Gillen, M ;
Chu, K ;
Rasmussen, C ;
Rasmussen, H ;
Kufe, D ;
Weichselbaum, R ;
Hanna, N .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (04) :592-601
[36]   Matrix metalloproteinases in tumor invasion and metastasis [J].
Stamenkovic, I .
SEMINARS IN CANCER BIOLOGY, 2000, 10 (06) :415-433
[37]  
TAMURA M, 1993, J BIOL CHEM, V268, P8140
[38]   THE 2 DIFFERENT RECEPTORS FOR TUMOR-NECROSIS-FACTOR MEDIATE DISTINCT CELLULAR-RESPONSES [J].
TARTAGLIA, LA ;
WEBER, RF ;
FIGARI, IS ;
REYNOLDS, C ;
PALLADINO, MA ;
GOEDDEL, DV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (20) :9292-9296
[39]   Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis [J].
Yoshida, S ;
Ono, M ;
Shono, T ;
Izumi, H ;
Ishibashi, T ;
Suzuki, H ;
Kuwano, M .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (07) :4015-4023
[40]  
Yu JH, 2003, J BIOCHEM MOL BIOL, V36, P49